Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis
Clinical trial NCT03009461 · COMPLETED
Trial details
- NCT number
- NCT03009461
- Sponsor
- Peking University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2020-06-15
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.